Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of ivabradine in combination with beta-blockers vs up-titration of beta-blockers in daily practice

Trial Profile

Efficacy of ivabradine in combination with beta-blockers vs up-titration of beta-blockers in daily practice

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Acronyms CONTROL-2
  • Sponsors Servier
  • Most Recent Events

    • 09 Mar 2018 New trial record
    • 05 Mar 2018 Primary endpoin (Change in heart rate during the 16-week treatment period)t has been met as per the results published in the Advances in Therapy
    • 05 Mar 2018 Primary endpoint (Number of angina attacks with standard therapy vs ivabradine) has been met as per the results published in the Advances in Therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top